Most Read Articles
Pearl Toh, 08 Jun 2016
Middle East Respiratory Syndrome (MERS) patients have more severe illness and a higher mortality rate than non-MERS severe acute respiratory infection (SARI) patients, according to a study presented at the recent American Thoracic Society (ATS) International Conference 2016 held in San Francisco, California, US.
Roshini Claire Anthony, 19 Sep 2016

Benralizumab reduced asthma exacerbations and improved lung function in patients with severe, eosinophilic asthma, according to results of the SIROCCO* and CALIMA** trials which were presented at the European Respiratory Society (ERS) International Congress 2016 held in London, UK.

01 Feb 2016
Ampicillin/sulbactam is an effective first-line therapy among elderly patients with Nursing- and Healthcare- associated Pneumonia (NHCAP), as observed in a retrospective analysis.
21 Apr 2016
At a recent continuing medical education programme, Dr Neil G Snowise, Regional Medical Leader of GlaxoSmithKline Global Respiratory Franchise shed light on the clinical efficacy of Relvar® Ellipta® (fluticasone furoate/vilanterol) for the management of asthma. Highlights of his presentation are summarized below.

The Role of Modern Second-generation Antihistamines in Allergic Rhinitis

25 Jul 2017
Allergic rhinitis (AR) is a common global health problem that poses a significant impact on the quality of life and productivity of affected patients. At the Ear, Nose and Throat (ENT) Summit 2017 held recently at  Hilton Sentral, Kuala Lumpur, Malaysia, Associate Professor Marysia P Tiongco-Recto was invited by A. Menarini to deliver a lecture on the potential of modern second-generation antihistamines, particularly bilastine (Bilaxten®) in the management of AR.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 08 Jun 2016
Middle East Respiratory Syndrome (MERS) patients have more severe illness and a higher mortality rate than non-MERS severe acute respiratory infection (SARI) patients, according to a study presented at the recent American Thoracic Society (ATS) International Conference 2016 held in San Francisco, California, US.
Roshini Claire Anthony, 19 Sep 2016

Benralizumab reduced asthma exacerbations and improved lung function in patients with severe, eosinophilic asthma, according to results of the SIROCCO* and CALIMA** trials which were presented at the European Respiratory Society (ERS) International Congress 2016 held in London, UK.

01 Feb 2016
Ampicillin/sulbactam is an effective first-line therapy among elderly patients with Nursing- and Healthcare- associated Pneumonia (NHCAP), as observed in a retrospective analysis.
21 Apr 2016
At a recent continuing medical education programme, Dr Neil G Snowise, Regional Medical Leader of GlaxoSmithKline Global Respiratory Franchise shed light on the clinical efficacy of Relvar® Ellipta® (fluticasone furoate/vilanterol) for the management of asthma. Highlights of his presentation are summarized below.